Topics of current lung cancer treatment imunoterapie, plicní karcinom, mutace, paliativní terapie in the Czech Republic to date 1. 8. 2020

Abstract

Reimbursement of pembrolizumab in combination with chemotherapy in the first line treatment of lung cancer to date 1. 8. 2020 has moved Czech guidelines towards international standards. Use of next generation sequencing also encouraged the approval of plenty new kinase inhibitors in lung cancer.

Pneumonology is a very progressive field dealing with complex oncological, supportive and palliative care of lung cancer patients.